Clinical Trial Update: A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers [Phase 1]

View source ↗

Summary

Phase 1 open-label study of Fruquintinib in advanced solid tumors, including metastatic colorectal cancer and metastatic breast cancer, has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)

Snippet

Sponsor: Hutchison Medipharma Limited | Conditions: Advanced Solid Tumors, Metastatic Colon Cancer | Phase 1 | Status: COMPLETED | Results posted: 2024-09-25